Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach. Asian Journal of Diabetology, [S. l.], v. 25, n. 2, p. 6–20, 2025. DOI: 10.59793/j8y5zv46. Disponível em: https://ojs.ijcp.in/index.php/AJD/article/view/1286. Acesso em: 6 dec. 2025.